VELTASSA Powder for oral suspension Ref.[8679] Active ingredients: Patiromer

Source: European Medicines Agency (EU)  Revision Year: 2024  Publisher: Vifor Fresenius Medical Care Renal Pharma France, 100–101 Terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris La Défense Cedex, France

Product name and form

Veltassa 1 g powder for oral suspension.

Veltassa 8.4 g powder for oral suspension.

Veltassa 16.8 g powder for oral suspension.

Veltassa 25.2 g powder for oral suspension.

Pharmaceutical Form

Powder for oral suspension.

Off white to light brown powder, with occasional white particles.

Qualitative and quantitative composition

Veltassa 1 g powder for oral suspension: Each sachet contains 1 g patiromer (as patiromer sorbitex calcium)

Veltassa 8.4 g powder for oral suspension: Each sachet contains 8.4 g patiromer (as patiromer sorbitex calcium).

Veltassa 16.8 g powder for oral suspension: Each sachet contains 16.8 g patiromer (as patiromer sorbitex calcium).

Veltassa 25.2 g powder for oral suspension: Each sachet contains 25.2 g patiromer (as patiromer sorbitex calcium).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Patiromer

Patiromer is a non-absorbed, cation exchange polymer that contains a calcium-sorbitol complex as a counterion. Patiromer increases faecal potassium excretion through binding of potassium in the lumen of the gastrointestinal tract. Binding of potassium reduces the concentration of free potassium in the gastrointestinal lumen, resulting in a reduction of serum potassium levels.

List of Excipients

Xanthan gum (for information about sorbitol see section 4.4)

Pack sizes and marketing

Veltassa 1 g powder for oral suspension

1 g of patiromer, as powder in sachets made of five layers: polyethylene, aluminium, polyethylene, polyester and paper.

Pack sizes: box of 60 sachets.

Veltassa 8.4 g powder for oral suspension

8.4 g of patiromer, as powder in sachets made of five layers: polyethylene, aluminium, polyethylene, polyester and paper.

Pack sizes: boxes of 30, 60 or 90 sachets and multipacks comprising 3 cartons, each containing 30 sachets.

Veltassa 16.8 g powder for oral suspension

16.8 g of patiromer, as powder in sachets made of five layers: polyethylene, aluminium, polyethylene, polyester and paper.

Pack sizes: boxes of 30, 60 or 90 sachets.

Veltassa 25.2 g powder for oral suspension

25.2 g of patiromer, as powder in sachets made of five layers: polyethylene, aluminium, polyethylene, polyester and paper.

Pack sizes: boxes of 30, 60 or 90 sachets.

Not all pack sizes may be marketed.

Marketing authorization holder

Vifor Fresenius Medical Care Renal Pharma France, 100–101 Terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris La Défense Cedex, France

Marketing authorization dates and numbers

EU/1/17/1179/001
EU/1/17/1179/002
EU/1/17/1179/003
EU/1/17/1179/004
EU/1/17/1179/005
EU/1/17/1179/006
EU/1/17/1179/007
EU/1/17/1179/008
EU/1/17/1179/009
EU/1/17/1179/010
EU/1/17/1179/011

Date of first authorisation: 19 July 2017
Date of latest renewal: 24 March 2022

Drugs

Drug Countries
VELTASSA Austria, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.